These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 7378262)

  • 1. The effect of age and thioridazine on the in vitro binding of fluphenazine to normal human serum.
    Rowell FJ; Hui SM; Fairbairn AF; Eccleston D
    Br J Clin Pharmacol; 1980 Apr; 9(4):432-4. PubMed ID: 7378262
    [No Abstract]   [Full Text] [Related]  

  • 2. Total and free serum haloperidol levels in schizophrenic patients and the effect of age thioridazine and fatty acid on haloperidol-serum protein binding in vitro.
    Rowell FJ; Hui SM; Fairbairn AF; Eccleston D
    Br J Clin Pharmacol; 1981 Apr; 11(4):377-82. PubMed ID: 7259931
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dopamine antagonism by thioridazine in schizophrenia.
    Meltzer HY; Sachar EJ; Frantz AG
    Biol Psychiatry; 1975 Feb; 10(1):53-7. PubMed ID: 1120175
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [SYSTEMATIC COMBINATION OF FLUPHENAZINE AND THIORIDAZINE APROPOS OF 87 CASES].
    SCHNETZLER JP; LAMAND JC; CASSASSUCE J
    Ann Med Psychol (Paris); 1963 Nov; 121():580-8. PubMed ID: 14097259
    [No Abstract]   [Full Text] [Related]  

  • 5. [Maintenance therapy with oenanthate of fluphenazine, associated with thioridazine and thymoanaleptics. Use of small doses].
    Schnetzler JP; Naveau C
    Ann Med Psychol (Paris); 1971 May; 1(5):800-6. PubMed ID: 5559010
    [No Abstract]   [Full Text] [Related]  

  • 6. Low neuroleptic serum levels in patients receiving fluphenazine decanoate.
    Tune LE; Creese I; Coyle JT; Pearlson G; Snyder SH
    Am J Psychiatry; 1980 Jan; 137(1):80-2. PubMed ID: 6101523
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High- and low-potency neuroleptics in elderly psychiatric patients.
    Branchey MH; Lee JH; Amin R; Simpson GM
    JAMA; 1978 May; 239(18):1860-2. PubMed ID: 347110
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug interaction between ascorbic acid and fluphenazine.
    Dysken MW; Cumming RJ; Channon RA; Davis JM
    JAMA; 1979 May; 241(19):2008. PubMed ID: 430792
    [No Abstract]   [Full Text] [Related]  

  • 9. Estimation of relative antiavoidance activity of depressant drugs in squirrel monkeys.
    Hanson HM; Witoslawski JJ; Campbell EH; Itkin AG
    Arch Int Pharmacodyn Ther; 1966 May; 161(1):7-16. PubMed ID: 4957465
    [No Abstract]   [Full Text] [Related]  

  • 10. Interaction between thioridazine and naltrexone.
    Maany I; O'Brien CP; Woody G
    Am J Psychiatry; 1987 Jul; 144(7):966. PubMed ID: 3605414
    [No Abstract]   [Full Text] [Related]  

  • 11. Characterization of phenothiazine-induced apoptosis in neuroblastoma and glioma cell lines: clinical relevance and possible application for brain-derived tumors.
    Gil-Ad I; Shtaif B; Levkovitz Y; Dayag M; Zeldich E; Weizman A
    J Mol Neurosci; 2004; 22(3):189-98. PubMed ID: 14997012
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of thioridazine and fluphenazine on the pituitary, thyroid and adrenal functions in patients with paranoid schizophrenia.
    Horodnicki JM; Czekalski S; Jarema M
    Psychiatr Pol; 1984; 18(3):205-11. PubMed ID: 6536002
    [No Abstract]   [Full Text] [Related]  

  • 13. [The serum fluphenazine level in patients with schizophrenia and the results of long-term treatment].
    Szukalski B; Lipska B; Welbel L; Nurowska K
    Psychiatr Pol; 1987; 21(1):26-31. PubMed ID: 3615674
    [No Abstract]   [Full Text] [Related]  

  • 14. [Blood serum concentration of long-acting fluphenazine in patients with various forms of schizophrenia].
    Pempkowiak L; Januszkiewicz-Grabiasowa A; Góra S
    Psychiatr Pol; 1979; 13(1):1-8. PubMed ID: 419224
    [No Abstract]   [Full Text] [Related]  

  • 15. [Thioridazine and fluphenazine].
    Holmberg G
    Nord Psykiatr Tidsskr; 1966; 20(5):394-400. PubMed ID: 5970308
    [No Abstract]   [Full Text] [Related]  

  • 16. Phenothiazines.
    Speicher CE; Walters MI
    Clin Lab Med; 1981 Sep; 1(3):547-57. PubMed ID: 6125291
    [No Abstract]   [Full Text] [Related]  

  • 17. Elevation of thioridazine plasma levels by propranolol.
    Silver JM; Yudofsky SC; Kogan M; Katz BL
    Am J Psychiatry; 1986 Oct; 143(10):1290-2. PubMed ID: 3766793
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of five antischizophrenic agents against Toxoplasma gondii in human cell cultures.
    Goodwin DG; Strobl JS; Lindsay DS
    J Parasitol; 2011 Feb; 97(1):148-51. PubMed ID: 21348624
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mitochondria and plasma membrane as targets of UVA-induced toxicity of neuroleptic drugs fluphenazine, perphenazine and thioridazine.
    Bastianon C; Zanoni R; Miolo G; Caffieri S; Reddi E
    Int J Biochem Cell Biol; 2005 Apr; 37(4):901-8. PubMed ID: 15694848
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FACTORS INFLUENCING THE CLINICAL RESPONSES OF SCHIZOPHRENIC PATIENTS TO PHENOTHIAZINE DRUGS AND TO PLACEBO.
    KLERMAN GL; DAVIDSON EM; KAYCE MM
    Psychiatr Res Rep Am Psychiatr Assoc; 1964 Dec; 19():97-115. PubMed ID: 14232660
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.